Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers
Clinical trial NCT07213089 · COMPLETED
Trial details
- NCT number
- NCT07213089
- Sponsor
- BioNet-Asia Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-13
- Primary completion
- 2022-04-04
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.